A detailed history of Modera Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Modera Wealth Management, LLC holds 368,775 shares of NVO stock, worth $38.7 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
368,775
Previous 376,986 2.18%
Holding current value
$38.7 Million
Previous $53.8 Million 18.4%
% of portfolio
0.56%
Previous 0.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $977,683 - $1.19 Million
-8,211 Reduced 2.18%
368,775 $43.9 Million
Q2 2024

Jul 29, 2024

SELL
$122.71 - $146.91 $3.47 Million - $4.15 Million
-28,269 Reduced 6.98%
376,986 $53.8 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $1.86 Million - $2.47 Million
-18,205 Reduced 4.3%
405,255 $52 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $1.42 Million - $1.71 Million
-16,185 Reduced 3.68%
423,460 $43.8 Million
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $19.5 Million - $42.7 Million
213,888 Added 94.74%
439,645 $40 Million
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $34.6 Million - $38.3 Million
221,587 Added 5313.84%
225,757 $36.5 Million
Q4 2022

Feb 07, 2023

BUY
$102.55 - $135.33 $130,033 - $171,598
1,268 Added 43.69%
4,170 $564,000
Q3 2022

Nov 01, 2022

BUY
$95.28 - $116.93 $2,572 - $3,157
27 Added 0.94%
2,902 $289,000
Q1 2022

May 03, 2022

SELL
$93.1 - $112.54 $5,306 - $6,414
-57 Reduced 1.94%
2,875 $319,000
Q2 2021

Aug 02, 2021

BUY
$67.66 - $84.76 $198,379 - $248,516
2,932 New
2,932 $246,000
Q1 2021

Apr 29, 2021

SELL
$67.06 - $75.82 $192,797 - $217,982
-2,875 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$63.89 - $73.8 $183,683 - $212,175
2,875 New
2,875 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Modera Wealth Management, LLC Portfolio

Follow Modera Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modera Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modera Wealth Management, LLC with notifications on news.